Literature DB >> 12814851

Susceptibility to neuroleptic-induced parkinsonism--age and increased substantia nigra echogenicity as putative risk factors.

Burkhard Emanuel Jabs1, Andreas Joachim Bartsch, Bruno Pfuhlmann.   

Abstract

OBJECTIVE: Patients treated by neuroleptics often develop neuroleptic-induced parkinsonism (NIP) to a varying extent. The reasons for this are discussed controversially in the literature. Previous transcranial sonography (TCS) findings of the substantia nigra (SN) in patients with idiopathic Parkinson's disease suggest a correlation of echogenicity with nigrostriatal dysfunction.
METHOD: One hundred psychiatric patients receiving neuroleptics were included. They underwent clinical examination for NIP (Simpson and Angus-scale) and, independently, TCS of the SN. History of smoking habits and medication were taken from the patient's chart.
RESULTS: We found a significant positive association of the prevalence of NIP with age (P < 0.01) and the echogenic area of the SN (P < 0.05). Neither type nor dosage of the neuroleptics was found to have any significant impact on the occurrence of NIP. Smokers displayed lower prevalence of NIP (P < 0.05) and lower EPS scores (P < 0.01).
CONCLUSIONS: These findings suggest that age and increased size of SN echogenicity are possible risk factors for NIP. In contrast, smoking seems to have a certain protecting effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814851     DOI: 10.1016/s0924-9338(03)00045-2

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  9 in total

Review 1.  A tipping point in drug dosing in late-life schizophrenia.

Authors:  Takashi Tsuboi; Takefumi Suzuki; Hiroyuki Uchida
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

2.  First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo.

Authors:  Kaidi Zhou; Jibran Y Khokhar; Bin Zhao; Rachel F Tyndale
Journal:  Biochem Pharmacol       Date:  2013-04-23       Impact factor: 5.858

3.  Detection, Assessment, and Management of Schizophrenia in an Andean Population of South America: Parkinsonism Testing and Transcranial Ultrasound as Preventive Tools.

Authors:  Mara Balda; Maria Calvó; Eduardo Padilla; Gonzalo Guerrero; Juan Molina; Nestor V Florenzano; Danielle Kamis; Javier I Escobar; C Robert Cloninger; Gabriel de Erausquin
Journal:  Focus (Am Psychiatr Publ)       Date:  2015

Review 4.  Sensitivity to antipsychotic drugs in older adults.

Authors:  Chloe Leon; Philip Gerretsen; Hiroyuki Uchida; Takefumi Suzuki; Tarek Rajji; David C Mamo
Journal:  Curr Psychiatry Rep       Date:  2010-02       Impact factor: 5.285

5.  Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population.

Authors:  Danielle Kamis; Lee Stratton; María Calvó; Eduardo Padilla; Néstor Florenzano; Gonzalo Guerrero; Beatriz Molina Rangeon; Juan Molina; Gabriel A de Erausquin
Journal:  Schizophr Res       Date:  2015-02-27       Impact factor: 4.939

6.  Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife.

Authors:  Julia Geissler; Thomas Jans; Tobias Banaschewski; Katja Becker; Tobias Renner; Daniel Brandeis; Manfred Döpfner; Christina Dose; Christopher Hautmann; Martin Holtmann; Carolin Jenkner; Sabina Millenet; Marcel Romanos
Journal:  Trials       Date:  2018-04-27       Impact factor: 2.279

7.  Transcranial sonography depicts a larger substantia nigra echogenic area in renal transplant patients on calcineurin inhibitors than on rapamycin.

Authors:  Nordeval Cavalcante Araújo; José Hermógenes Rocco Suassuna; Rita de Cássia Leite Fernandes
Journal:  BMC Nephrol       Date:  2022-03-17       Impact factor: 2.388

8.  Substantia Nigra Echogenicity Predicts Response to Drug Withdrawal in Suspected Drug-Induced Parkinsonism.

Authors:  Jose L López-Sendón Moreno; Araceli Alonso-Cánovas; Javier Buisán Catevilla; Nuria García Barragán; Iñigo Corral Corral; Alicia de Felipe Mimbrera; María Consuelo Matute Lozano; Jaime Masjuan Vallejo; Juan Carlos Martínez-Castrillo
Journal:  Mov Disord Clin Pract       Date:  2015-12-18

9.  Metoclopramide and Levosulpiride Use and Subsequent Levodopa Prescription in the Korean Elderly: The Prescribing Cascade.

Authors:  Youn Huh; Do-Hoon Kim; Moonyoung Choi; Joo-Hyun Park; Do-Young Kwon; Jin-Hyung Jung; Kyungdo Han; Yong-Gyu Park
Journal:  J Clin Med       Date:  2019-09-19       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.